Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to monitor the safety and tolerability of vericiguat.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06428383
Study type Interventional
Source Merck Sharp & Dohme LLC
Contact
Status Not yet recruiting
Phase Phase 3
Start date June 3, 2024
Completion date April 15, 2032

See also
  Status Clinical Trial Phase
Recruiting NCT01913847 - Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension Phase 3
Terminated NCT00232388 - Association of PICP Serum Marker in Patients With LVSD Phase 1
Completed NCT00211874 - Improving Heart Failure Care in Minority Communities N/A
Completed NCT00689819 - Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients N/A
Completed NCT05175066 - Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity Phase 3
Recruiting NCT05519046 - Cardiac Contractility Modulation in Chagas Heart Disease N/A
Recruiting NCT04476576 - Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy N/A
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Not yet recruiting NCT03938090 - Optimised MultiSite Pacing Vector Study N/A
Recruiting NCT05408559 - Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES Phase 1/Phase 2
Completed NCT01529463 - Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients N/A
Terminated NCT02450110 - A Pilot Study of Spinal Cord Stimulation in Heart Failure Patients With Depressed Left Ventricular Function N/A
Recruiting NCT05796050 - Sex Related Differences in Cardiac Function
Completed NCT06129448 - Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Type 1 Diabetes Mellitus
Completed NCT03349593 - Prevalence of Hypovolemia and Heart Failure in Non-cardiac Surgery